approval · primary record
DABIGATRAN ETEXILATE MESYLATE
FDA · NDA · 2025-06-17
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-06-17 |
| Brand | PRADAXA |
| Sponsor | BOEHRINGER INGELHEIM |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:42.163Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DABIGATRAN ETEXILATE MESYLATE:2025-06-17
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.